For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can ...
Early Versus Delayed Androgen Deprivation for Prostate Cancer: New Fuel for an Old Debate Traditionally, prostate cancer treatment, as well as all cancer treatment, has been designed to target the ...
Docetaxel rechallenge significantly improved survival compared with cabazitaxel in certain men with metastatic ...
News-Medical.Net on MSN
Human insight and AI advance prostate cancer treatment
Today, many men must choose between life-altering prostate removal or careful long-term monitoring. The EU-funded ROBIOSPY ...
Former President Joe Biden's office announced Sunday that he has been diagnosed with an "aggressive" form of prostate cancer, which has spread to his bones. But it said the cancer appears to be ...
JongSoo Lee, Ph.D., Mathematics & Statistics, Kennedy College of Sciences, University of Massachusetts Lowell Camilla Pimentel, Ph.D., Public Health, Zuckerberg ...
Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a medicine that is used to treat prostate cancer in adults. Pluvicto may be used to treat PSMA-positive prostate cancer that has spread to other ...
If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results